Skip to content

PHARMAEXPRESS

Active
Private limited companyfounded 2020active for 6 yearsRue de l'Avenir 12, 4890 Thimister-Clermont, BelgiumKBO/BCE: BE 0743.800.651
Summary

PHARMAEXPRESS has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €576,313 and a net result of €162,647. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 95% of 1,675 sector peers (NACE 62, financial year 2025). The computed 12-month bankruptcy probability is 1.0% (low).

Directors

Directors

Statutory auditor 1

Soc. Civ. SCRL BDO Réviseurs d'Entreprises
Statutory auditor · since 21-05-2026 · permanent representative: Catherine GREGOIRE
Current
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →

Mandate history

1 person since 2026, 1 in office
Show
  • Statutory auditor
Mandates per person, with start and end dates
Name Functions and periods
Soc. Civ. SCRL BDO Réviseurs d'Entreprises
  • Statutory auditor, from 21-05-2026 to date
See the board, name and registered office on a given date →

Owners and capital

Owners

1 owner

Chain of control

  1. Solidarité 99.96%
  2. COMEPAR 1 77.14%
  3. PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT 100%
  4. PHARMAEXPRESS

Highest known parent: Solidarité. The sources do not say who stands above it.

Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.